Cyclin-dependent kinase 4/6 inhibitors in granulosa cell tumors and their combination with hormonal therapy: a scoping review - Top-Institutions - MDSpire

Cyclin-dependent kinase 4/6 inhibitors in granulosa cell tumors and their combination with hormonal therapy: a scoping review

  • By

  • Pacholczak-Madej, Renata

  • Łupkowski, Radosław

  • Górniak, Karolina

  • Puskulluoglu, Mirosława

  • June 26, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

  • #2

    Robert H. Lurie Comprehensive Cancer Center Northwestern University Feinberg School of Medicine
    Robert H. Lurie Comprehensive Cancer Center Northwestern University Feinberg School of Medicine

    Chicago, IL

    Key Differentiators

    • Oncology

  • #3

    Lynn Sage Breast Cancer Symposium
    Lynn Sage Breast Cancer Symposium

    Chicago, IL

    Key Differentiators

    • Oncology

  • #4

    The Ohio State University Comprehensive Cancer Center
    The Ohio State University Comprehensive Cancer Center

    Columbus, OH

    Key Differentiators

    • Oncology

  • #5

    Duncan Cancer Center at Baylor College of Medicine
    Duncan Cancer Center at Baylor College of Medicine

    Houston, TX

    Key Differentiators

    • Oncology

Original Source(s)

Cyclin-dependent kinase 4/6 inhibitors in granulosa cell tumors and their combination with hormonal therapy: a scoping review

  • by Pacholczak-Madej, Renata , Łupkowski, Radosław , Górniak, Karolina , Puskulluoglu, Mirosława

  • June 26, 2026

Related Content

Integrative oncology in colorectal cancer: evidence-based strategies from prevention through survivorship

Algebraic evaluation of optimization in tumors classification with numerical assessments via a flask–react web interface

Management challenges in metachronous bilateral breast cancer with discordant receptor status: a case report